Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival

Am J Cardiol. 1995 Oct 1;76(10):739-41. doi: 10.1016/s0002-9149(99)80214-8.


Cardiac amyloidosis has a poor prognosis, with a median survival of approximately 6 months once symptoms develop. This patient had a markedly improved quality of life with cardiac transplantation. We would suggest that with refinement of pretransplant chemotherapy, prolonged survival may be possible in carefully selected cases.

Publication types

  • Case Reports

MeSH terms

  • Amyloidosis / diagnostic imaging
  • Amyloidosis / surgery*
  • Cardiomyopathies / diagnostic imaging
  • Cardiomyopathies / surgery*
  • Echocardiography
  • Female
  • Heart Transplantation*
  • Humans
  • Middle Aged
  • Recurrence
  • Survivors